Product Program year 2019 Source: CMS Open Payments

None

Drug Non-Brandeddisease State

Open in the dashboard

General payments

$885,353

1,034 payments

Research payments

$1,078,286

116 payments

Through program year 2019, $885,353 in general payments and $1,078,286 in research payments were reported against None (Non-Brandeddisease State).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $885,353 1,034
2019 Research $1,078,286 116

Breakdown

Who paid General payments · program year 2019
  1. United Therapeutics Corporation $885,353 1,034 payments
Top recipients General payments · program year 2019
  1. Cleveland Clinic Hospital Teaching hospital · OH $85,500 10% · 2 payments
  2. Lana Melendres Groves Pulmonary Disease · Albuquerque, NM $48,686 5% · 63 payments
  3. Ronald Oudiz Cardiovascular Disease · Torrance, CA $41,696 5% · 48 payments
  4. Franck Rahaghi Pulmonary Disease · Weston, FL $32,500 4% · 30 payments
  5. Oksana Shlobin Critical Care Medicine · Falls Church, VA $30,351 3% · 28 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pulmonary Disease Internal Medicine $442,299 59% · 127 practitioners
  2. Cardiovascular Disease Internal Medicine $114,856 15% · 36 practitioners
  3. Advanced Heart Failure and Transplant Cardiology Internal Medicine $87,036 12% · 14 practitioners
  4. Critical Care Medicine Internal Medicine $80,127 11% · 22 practitioners
  5. Internal Medicine $9,017 1% · 30 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Ohio $157,483 18% · 16 recipients
  2. California $143,523 16% · 27 recipients
  3. Florida $125,783 14% · 66 recipients
  4. Pennsylvania $56,945 6% · 21 recipients
  5. New Mexico $48,936 6% · 3 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

1,034 general · 116 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record